HCPCS Level IIdrugActive
J9359
Inj lon tesirin-lpyl 0.075mg
BETOS: O1E
Effective: 2022-04-01
Description
Injection, loncastuximab tesirine-lpyl, 0.075 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Zynlonta
Manufacturer
ADC Therapeutics America, Inc.
HCPCS Dosage
0.075 MG
Billing Units
133.3300
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.